Medicare will start covering weight-loss drugs on July 1 for the first time
The temporary demonstration sidesteps a federal ban on obesity-only coverage and could save beneficiaries thousands of dollars a year.
- On July 1, the Centers for Medicare & Medicaid Services will launch the Medicare GLP-1 Bridge program, marking the first time Medicare will help pay for drugs prescribed solely for obesity.
- Federal law prohibits Medicare from covering weight-loss drugs, prompting the administration to conduct this temporary demonstration project following an agreement with Eli Lilly and Novo Nordisk to reduce costs.
- Eligible enrollees pay $50 monthly, though this copayment does not count toward annual out-of-pocket maximums; patients must have a BMI of 35 or higher, or lower BMI with specific health conditions, to qualify.
- Medicare beneficiaries who already receive GLP-1 drugs for diabetes or sleep apnea will continue using their regular Part D prescription drug coverage, as the pilot excludes those already covered.
- Running through the end of 2027, the Bridge program offers no clear path forward for coverage once it lapses; unless Congress changes the law or CMS issues an extension, patients may face higher cash prices.
71 Articles
71 Articles
Medicare Launches New Weight Loss Drug Pipeline.
Medicare’s new weight-loss drug program offers affordable access to GLP-1 medication for seniors, marking a significant shift in healthcare coverage and efforts to combat obesity.PULSE POINTS WHAT HAPPENED: Medicare’s first-of-its-kind weight-loss drug program has officially launched, giving American seniors access to GLP-1 drugs at a subsidized cost. DETAIL: On Wednesday, Medicare & Medicaid Services launched a new program allowing Americans ag…
Medicare begins covering weight-loss medications: who qualifies and how the new program will work
For years, many older Americans with obesity watched as medications like Wegovy and Zepbound revolutionized weight-loss treatment yet remained out of their reach due to their high cost and Medicare restrictions. Starting July 1, 2026, that will change thanks to a new temporary program that will provide access to these treatments for a copay of $50 per month.Seguir leyendo
NBC Chicago
Medicare now covers GLP-1 weight-loss drugs for $50 a month: See if you’re eligible
Popular GLP-1 weight-loss drugs are becoming much more affordable for millions of older adults starting Wednesday, July 1, as Medicare begins to cover them — for now. The Medicare GLP-1 Bridge is a temporary pilot program that allows eligible Medicare recipients to get blockbuster anti-obesity medications like Wegovy and Zepbound for $50 a month. Medicare is federal health insurance for people who are 65 or older. The GLP-1 Bridge is temporary b…
GLP-1 weight loss drugs are now $50 a month for some Americans. Here’s who qualifies
Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans.Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare GLP-1 Bridge.The temporary program, which runs until the end of 2027, is the first opportunity for most older adults to get GLP-1s, short for glu…
Coverage Details
Bias Distribution
- 65% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
